COSCIENS Biopharma Inc. (CSCI) — Net Asset Quality Index
COSCIENS Biopharma Inc. (CSCI) has a Net Asset Quality Index of 25.8% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $27.56 Million minus total liabilities of $20.46 Million yields net assets of $7.10 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore COSCIENS Biopharma Inc. asset portfolio for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
COSCIENS Biopharma Inc. Net Asset Quality Index Over Time (1996–2024)
This chart shows how COSCIENS Biopharma Inc.'s Net Asset Quality Index has evolved across 29 annual periods from 1996 to 2024. As of June 2025, the index stands at 25.8%, representing net assets of $7.10 Million against total assets of $27.56 Million USD. See COSCIENS Biopharma Inc. (CSCI) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for COSCIENS Biopharma Inc. (1996–2024)
The table below presents the year-by-year Net Asset Quality Index for COSCIENS Biopharma Inc. from 1996 to 2024, covering 29 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see COSCIENS Biopharma Inc. stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 37.5% | $13.16 Million | $35.07 Million | $21.91 Million | ▼ -51.1 pp |
| 2023 | 88.6% | $21.04 Million | $23.75 Million | $2.71 Million | ▲ +3.0 pp |
| 2022 | 85.6% | $23.79 Million | $27.80 Million | $4.01 Million | ▼ -3.7 pp |
| 2021 | 89.3% | $21.74 Million | $24.35 Million | $2.61 Million | ▲ +6.1 pp |
| 2020 | 83.2% | $19.06 Million | $22.92 Million | $3.85 Million | ▲ +1.4 pp |
| 2019 | 81.8% | $17.08 Million | $20.88 Million | $3.79 Million | ▼ -9.8 pp |
| 2018 | 91.7% | $17.04 Million | $18.59 Million | $1.55 Million | ▲ +10.6 pp |
| 2017 | 81.1% | $17.93 Million | $22.11 Million | $4.19 Million | ▼ -3.8 pp |
| 2016 | 84.9% | $16.67 Million | $19.64 Million | $2.97 Million | ▲ +34.7 pp |
| 2015 | 50.2% | $5.68 Million | $11.32 Million | $5.64 Million | ▲ +22.9 pp |
| 2014 | 27.2% | $1.80 Million | $6.62 Million | $4.82 Million | ▲ +22.4 pp |
| 2013 | 4.8% | $229.62K | $4.79 Million | $4.56 Million | ▲ +4.4 pp |
| 2012 | 0.3% | $13.63K | $3.91 Million | $3.89 Million | ▼ -12.1 pp |
| 2011 | 12.4% | $507.11K | $4.09 Million | $3.58 Million | ▲ +35.6 pp |
| 2010 | -23.2% | $-654.90K | $2.82 Million | $3.47 Million | ▲ +26.3 pp |
| 2009 | -49.5% | $-1.31 Million | $2.65 Million | $3.96 Million | ▲ +9.2 pp |
| 2008 | -58.7% | $-1.59 Million | $2.70 Million | $4.29 Million | ▼ -92.6 pp |
| 2007 | 33.9% | $1.57 Million | $4.63 Million | $3.06 Million | ▲ +19.1 pp |
| 2006 | 14.7% | $260.64K | $1.77 Million | $1.51 Million | ▼ -4.3 pp |
| 2005 | 19.1% | $397.23K | $2.08 Million | $1.69 Million | ▲ +12.4 pp |
| 2004 | 6.6% | $94.89K | $1.43 Million | $1.33 Million | ▼ -23.8 pp |
| 2003 | 30.4% | $294.75K | $968.03K | $673.27K | ▲ +131.6 pp |
| 2002 | -101.2% | $-414.76K | $409.92K | $824.69K | ▲ +203.5 pp |
| 2001 | -304.6% | $-714.40K | $234.50K | $948.90K | ▲ +508.2 pp |
| 2000 | -812.8% | $-1.59 Million | $196.16K | $1.79 Million | ▼ -160.7 pp |
| 1999 | -652.2% | $-1.31 Million | $201.16K | $1.51 Million | ▼ -432.2 pp |
| 1998 | -220.0% | $-714.89K | $324.95K | $1.04 Million | ▼ -291.8 pp |
| 1997 | 71.8% | $6.57 Million | $9.15 Million | $2.59 Million | ▲ +28.7 pp |
| 1996 | 43.0% | $5.84 Million | $13.57 Million | $7.73 Million | — |